-A 5 year old boy with autism goes into a cardiac arrest and dies because of a controversial treatment.
-This was the childs third treatment at Advanced Integrative Medicine Center in Portersville, Pa.
-This treatment can possibly remove vital minerals from the body and possibly have death in the near future.
The boy, Abubakar Nadama, went into cardiac arrest while undergoing chelation therapy. Chelation is used to remove heavy metals from the blood. It's approved for acute lead poisoning. No form of chelation therapy is approved by the FDA for treating autism. The treatment given to Abubakar was intravenous EDTA -- ethylene diamine tetra-acetic acid. This situation angers autism expert Leslie Rubin, "I say this emphatically: Chelation is a very risky procedure with no proven benefits for children with autism or related conditions," Rubin tells WebMD. But many parents believe their children's autism is caused by mercury from thimerosal, a vaccine preservative. A recent Institute of Medicine (IOM) report explicitly rejects this theory. That report also finds no evidence that chelation helps autism. Says Sallie Bernard, executive director of Safe Minds, "The boy who died was using a form of chelation therapy that is not generally recommended or widely practiced within the autism community trying chelation," Bernard tells WebMD. "It is an unusual circumstance. EDTA is not what most of these parents are doing. It is not what is considered the right form of chelation." This controversy is very crucial and people who are part of the actual procedure of therapy for autism, need to absolutely know if the type of therapy that is being done, is proven to work and have no side effects.
By: Daniel J. DeNoon
Title: Boy Dies Afetr Controversial Treatment for Autism
Sources: SOURCES: The Pittsburgh Tribune-Review, Aug. 25 and Aug. 26, 2005. Leslie Rubin, MD, Emory and Morehouse universities, Atlanta; president, Institute for the Study of Disadvantage and Disability. Susan Hyman, MD, associate professor of pediatrics, Strong Children's Research Center, University of Rochester, N.Y. Sallie Bernard, executive director, Safe Minds.
Publication Date: August 26, 2005
Date Accessed the Info: May 19,2010
URL: http://www.webmd.com/brain/news/20050826/boy-dies-after-controversial-treatment-for-autism
No comments:
Post a Comment